Summary: Local CMRG1c values were determined for 13 regions in each hemisphere from tomographs of patients with Alzheimer's, Huntington's, and Parkinson's dis eases who were studied using [lsFJfluorodeoxyglucose with positron emission computed tomography. Intercor relations among the 26 regional measures were calculated for each disease state and for normal controls, and were accepted as reliable at p < 0.0 1, uncorrected for the number of comparisons. The number of reliable correla-
The development of positron emission tomog raphy (PET) has made possible the evaluation of brain metabolism and blood flow in tomographic brain sections. The technique has been applied to a number of degenerative disorders of the nervous system including Alzheimer's disease (Frackowiak et aI., 1981; Farkas et aI., 1982; Benson et aI., 1983; deLeon et aI., 1983a,b; Friedland et aI., 1983; Kuhl et aI., 1983 ), Parkinson's disease (Lenzi et aI., 1979; Leenders et aI., 1983; Rougemont et aI., 1983; Kuhl et aI., 1984) , and Huntington's disease (Kuhl et aI., 1982) . Brain metabolism has been found to be strik ingly reduced in Alzheimer's disease and mildly to moderately reduced in Parkinson's disease, whereas in Huntington's disease, major metabolic depression has been found only in the caudate nu cleus. The prominent difference in brain metabo lism between Alzheimer's, Parkinson's, and Hun tington's diseases is consistent with primary cor-tions was found to be decreased in Parkinson's and Hun tington's diseases, two primarily subcortical disorders, and increased in Alzheimer's disease, a primarily cortical disorder. The changes suggest that one role of the basal ganglia involves coordinating or pacing the ability of cor tical brain regions to function as a unit. Key Words: Alz heimer's disease-Fluorodeoxyglucose-Glucose me tabolism-Huntington's disease-Parkinson's disease Positron emission tomography.
tical pathology in the first disorder and basal ganglial dysfunction in the latter two.
In this study, we have reexamined data from sub jects with these three disorders who had been in vestigated at UCLA (Los Angeles, CA, U.S.A.) using [ lS F]fluorodeoxyglucose (FDG). In our pre vious studies, the key question had been whether specific global or regional metabolic differences were present between patients with each disease and appropriate controls. We are now concerned with how brain metabolism interrelates between re gions (Fig. 1) . Under normal circumstances, a single brain area does not function in isolation, but rather in an environment where it interacts with other brain regions. When metabolism is altered in a single region, the alteration will affect the metab olism of other brain areas with which it interrelates. Since regional metabolism is a measure of local brain function, the correlations between regional metabolism should give an index of the functional relationship between the two regions within the sample of subjects (Metter et aI., 1984 In normal subjects, the pres ence of a strong interaction between the metabolism of two regions across subjects suggests a functional rela tionship between the two regions, whereas the patterning suggests a functional system. If such relation ships can be defined in normal sub jects, the loss of these relationships in the disease state may be responsible for some aspects of the clinical state.
in subjects with a given clinical state (although non linear relationships may exist); and whether the de gree of regional correlations changes across dis eases.
Using this approach in comparing Alzheimer's, Huntington's, and Parkinson's diseases, we asked (a) whether the number of cortical-to-cortical cor relations would differ across disease states, (b) whether the distribution of correlations would differ from that in normals, and (c) whether this approach would be a useful alternative technique for exam ining brain metabolic data.
METHODS

Patients
FDG scans were reviewed from the UCLA data base of subjects who had Huntington's, Parkinson's, or Alz heimer's disease and from age-matched controls. Tw elve patients with Huntington's disease were identified, with an average age of 42 years, who were previously included in a report by . The patients crossed the full spectrum from mild to severe disease. In addition, seven patients with Parkinson's disease were examined, who were reported by and who were being treated with L-3,4-dihydroxyphenylalanine. Their average age was 64 years. Eight patients with Alz heimer's disease, with an average of 68 years, were studied, who had been reported by Benson et a!. (1983) . They were moderately to severely demented at the time they were examined.
Two separate control groups were included because of differences in ages in the three disease groups and be cause of the previous report by of a trend toward a decrease in metabolism with age. For the older Alzheimer's and parkinsonian patients, 17 subjects were examined in the age range of 50-78 years with an average age of 62 years. For the younger Huntington's disease patients, 14 controls aged 24-50 years had an average age of 42 years.
Scanning
All subjects were scanned with FDG on the ECAT II (Ortec, Oak Ridge, TN, U.S.A.) with resolution of 1.6 cm full width at half maximum (Phelps et a!., 1978) . Iso tope preparation, scanning protocol, validation of the method, and details of scanning techniques have been previously reported (Phelps et a!., 1979; Huang et a!., 1980) . Basically, 5-10 mCi FDG was injected, and serial arterialized venous blood samples were taken. The pa tients lay quietly in a resting state on the ECAT bed with eyes and ears open for 40 min following injection, essen tially seeing and hearing the ambient conditions within the laboratory. After 40 min, multiple scans were taken parallel to the canthomeatal line, and were completed after the accumulation of 2-3 million counts per image. Image values were converted to local CMRGlc (LCMRGlc) based on the model of Huang et al. (1980) and Phelps et al. (1979) using constants derived from normal young adults in units of fLmollmin/lOO g.
The metabolic scans were displayed on a video monitor from which regions of interest were outlined. Thirteen regions were selected from each hemisphere (Fig. 2) , in cluding measures of frontal (F3, F2, Fl), Broca's (B2, BI), parietal (P), superior temporal gyrus (W2, WI), pos terior middle and inferior temporal gyrus (T2, Tl), occip ital (0), caudate (Cd), and thalamic (TH) regions. The regions were measured from three tomographic sections, which were perisylvian in location, and are illustrated on the right in Fig. 2 .
LCMRGlc was converted to what will be called a "ref erence ratio" by dividing each regional value by the mean of the 26 regions for the subject. This measurement was utilized to minimize effects due to measurement errors and individual variations in mean glucose metabolism (Phelps et aI., 198 1) and because the principal interest of the study was in regional variation, not absolute metab olism. We have applied this same measure in other studies (M etter et aI., 1984) . The reference ratio is equiv alent to the landscape method used by Phelps et a!. (198 1) and by Mazziota et al. (1982) for brain stimulation para digms.
RESULTS
LCMRGIc values for Alzheimer's disease, Par kinson's disease, and Huntington's disease from our laboratory have previously been reported (Benson et aI., 1983; Kuhl et aI., 1982 Kuhl et aI., , 1984 , but not for the specific regions measured in this study. Mean values for the 13 brain regions from the left hemisphere for each of the three clinical and two control groups are shown in Fig. 3 . Note that re gional metabolism for Parkinson's disease is in the lower normal range for all regions and that the depression is constant across all regions measured,
Regions of interest: Thirteen regions were evaluated from each hemisphere from transverse scans, as illustrated on the right. Corresponding levels were compared with sec tions at 0° to the canthomeatal line from the atlas of Matsui and Hirano (1978) . The metabolic regions from transverse sections were then projected onto the lateral brain surface. The top right scan was projected to the top row on the lateral projection, the middle scan to the middle row, and the lowest scan to the lowest row. The numbering was 3 for measure ments from the top scan, 2 for the middle scan, and 1 for the lowest scan. Areas B1, B2, and W2 fold into the sylvian fis sure and do not cross it. Areas: F, frontal; B, Broca's; W, superior temporal; T, posterior middle inferior temporal; 0, occipital; Cd, head of caudate; TH, thalamic.
so that the profile of regional metabolism was the same as for age-matched controls. have shown that global metabolism in Parkinson's disease is moderately decreased compared with that in age-matched controls. In Huntington's disease, LCMRGlc did not differ significantly from normal for any region except the caudate nucleus, and the profile was the same as that of their age-matched control group except for the caudate region. A dif ferent picture is noted for these 13 regions in Alz heimer's disease, with the LCMRGlc being mark edly depressed for all regions, except the occipital values, which approached the normal rates for that region.
Further analysis obtained by converting the data to reference ratios is shown in Fig. 4 . Since the reference ratios for the younger and older controls were not statistically different, they were combined for this figure. Note that the profiles of ratios are essentially the same across disease states, except in Huntington's disease, where there is a markedly decreased caudate reference ratio, and in Alz- heimer's disease, with an elevation in the occipital measure and temporal and frontal measures seeming slightly depressed. The remaining regional reference ratios were similar for each disease. The data as presented in Figs. 3 and 4 represent the traditional approach used for analyzing disease states by comparing regional measures across the groups. What was most striking was the depression of caudate in Huntington's disease and the diffuse metabolic depression in Alzheimer's disease. A small but significant depression was also noted in Parkinsonian global metabolic rates.
Regional relationships were studied by examining region-to-region correlations of the reference ratios for each disease. Reliable correlations, i.e., corre-
'" .8 lations exceeding an adjusted significance of p < \) .\)5, are shown in Figs. 5 -1 . Re\iab\e cone\ations were derived from critical correlation coefficient (r) values selected for each group of subjects where p < 0.01, unadjusted for the number of measures. Each critical correlation coefficient (r) was ac cepted as reliable only after adjustment by the Bon ferroni inequality test and by testing against a pop ulation correlation coefficient. Since each matrix of 26 measures would call for a family of 325 tests of correlations below the diagonal, an overall signifi cance level of p < 0.05 was reduced by this number of possible tests and its probability density con verted to normal variate score so that a critical" t " to critical "r" conversion could be applied (Hays, 1973) . The calculated r values did not differ from an accepted critical r value at p < 0.01 by testing using Fisher r to z transformation. With the many comparisons, statistical significance cannot be ad equately considered; rather, what are demonstrated are trends in regional relationships. For each matrix (Figs. 5-7), the region-to-region reliable correla tions are shown for (a) the disease state and (b) the age-matched control. The reference ratios for the disease and control groups were found to be nor mally distributed and had no outliers. The differences in numbers of cortical-to-cortical reliable correlations (i.e., excluding the correlations involving the caudate and thalamus-the bottom four rows in Figs. 5-7) in the three disease states and corresponding controls are shown in Ta ble 1. A decline was found in the number of cortical-to-cor tical reliable correlations in both Huntington's and Parkinson's disease. Also, a change occurred in the distribution of the reliable correlations as compared with controls. In Parkinson's disease, a loss was found of high frontal reliable correlations to parietal and occipital regions (the first two columns in Fig.  7) . The remaining cortical-to-cortical reliable cor relations were primarily to the left Broca's region. In Huntington's disease (Fig. 6) , there was a similar decrease in reliable correlations between high frontal, parietal, and occipital areas as compared with control, though the loss was not as extensive as in Parkinson's disease. Also, in both disease states, a decrease was found in the reliable corre lations between homologous regions in each hemi sphere. These are the correlations along the diag onal as seen in the controls.
Alzheimer's disease (Fig. 5) showed a very dif ferent patterning from the two subcortical diseases, with an increase in the number of cortical-to-cor tical reliable correlations. The increase was in the correlations of frontal-to-frontal regions and tem poral-to-temporal areas.
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FIG. 5.
Summary of all reliable correlations for Alzheimer's disease (A) as compared with those for an age-matched con trol (filled circles). Region-to-region correlations of reference ratios were calculated for each pair of the 26 regions from Fig. 2 . Each calculated r was compared with corresponding critical r for the group of subjects and was accepted as re liable when greater or equal to the critical correlation coef ficient. When a reliable correlation was found for Alzheimer's subjects, an A was placed in the corresponding box within the matrix. Likewise, when a reliable correlation was present in the control, a filled circle was placed there. Only correla tions that were reliable are shown. Negative correlations are shown by a negative sign. The critical correlation coefficient for Alzheimer's disease was 0.83 and for the age-matched control 0.61. The regions are identified with the same abbre viations as in Fig. 2 (L, left; R, right).
DISCUSSION
The approach reported here is an alternative way to evaluate data from FDG PET brain imaging. Dif ferences in regional correlations among the three disease states and appropriate controls were quite striking. The decrease in cortical-to-cortical meta bolic correlations in Parkinson's and Huntington's diseases, both subcortical diseases, suggests a pos sible role for the basal ganglia in cortical-to-cortical communication. The observed findings would not have been recognized by typical regional analyses, demonstrating that alternative approaches may have value.
Before discussing the possible significance of these observations, it is important to consider lim itations in the study: (a) A large number of variables were compared in small samples. The statistical method was not designed specifically for this type of comparison. The use of the method in the study was as a descriptive tool, where the interest was in identifying trends in region-to-region metabolic ac-
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.... .... tlVlty. Ideally, this type of study should be done with large samples, so the results should be consid ered primarily in relation to the studied samples. (b) The understanding of the FDG model as it applies to these disease states is somewhat limited. The kinetic constants appear essentially unchanged with aging and Alzheimer's disease (Friedland et aI., 1983; Hawkins et aI., 1983 ), but they have not been studied in Parkinson's and Huntington's diseases, whereas the lumped constant has not been studied in any of the states. We have assumed their stability in this study. The effects of errors caused by dif ferences in constants, however, should be minimal, since matrices were based on the reference ratio.
(c) No adjustments have been made for structural changes that may occur in brain disease or with aging as can be observed on computed tomography (CT). Herscovitch et al. (1983) suggest that such corrections are necessary to normalize flow or me tabolism in relation to atrophy. CT scans were not done on control subjects in this study, as it seemed to be an unjustifiable exposure to radiation. The FDG studies in Huntington's and Parkinson's dis eases showed that LCMRGIc values were similar in profile on cortical region-to-region comparisons as in controls (Fig. 4) . If atrophy were a significant factor in either disease as compared with controls, then perisylvian metabolism (F I, B I, P, W2) should have been relatively depressed in relation to other brain regions, as this is where earliest atrophic changes are frequently seen. Also, Fabre et al. (1983) found no relations between the degree of hy perfrontality in blood flow and atrophy in a sample of patients with Parkinson's disease, suggesting that the degree of atrophy occurring with parkinsonism is not associated with major changes in measured regional CBF (rCBF) and correspondingly with LCMRGIc. The role of the basal ganglia in the control of cortical brain function is poorly understood (Divac and Oberg, 1979) . It is obvious that the basal ganglia are involved in the organization and planning of se- The numbers represent how many reliable region-to-region correlations were present between cortical areas for each group.
Separate age-matched controls were used for the three groups.
Alzheimer's patients had an average age of 68, Parkinson's pa tients 62 years, and the controls 64 years, whereas Huntington's patients averaged 44 years and the controls 42 years.
quential processing of movements and perhaps of cognition and other behaviors. The role does not seem to be associated with input but rather with the execution of the desired response. This function seems to involve feedback loops arising from the cortex, going through the basal ganglia, thalamus, and back to cortex, which implies that the basal ganglia modify cortical activity. The function in cludes extensive innervation at the level of the head of the caudate from frontal regions and the putamen from parietal areas (Kemp and Powell, 1970) . The overall role of these feedback loops on the cortex is not known. The findings of a decrease in the number of cor tical-to-cortical correlations in Huntington's and Parkinson's diseases suggest that one basal ganglial function is to act as a pacemaker that coordinates communication and functional cooperation between cortical regions. Such an action could explain the basal ganglial roles in movement and behavior. By coordinating cortical region-to-region interactions, an efficiency of action can occur at all levels of a behavior by allowing for optimal communication between those regions involved with planning and execution. Disruption of this efficiency in commu nication results in a delay or disruption of tasks relying on multi modal interactions. Consistent with this, Yeterian and Van Hoesen (1978) noted in the rhesus monkey that cortical areas showing strong cortical-to-cortical interconnections shared at least one common area of projection in the caudate nu cleus, whereas cortical regions without strong in terconnections did not necessarily share caudate projections.
Other functional studies have shown cortical ab normalities in Parkinson's disease, including a 10% generalized decline in global blood flow and oxygen metabolism (Lavy et aI., 1979; Bes et aI., 1983) , associated with loss of hyperfrontality in one study (Bes et aI., 1983 ) and a decline in parietal oxygen metabolism in a second (Lenzi et aI., 1979) . No cor relation was found between degree of rCBF depres sion and degree of dementia (Globus et aI., 1983) . Fabre et al. (1983) suggested that the flow changes are not primarily cortical phenomena, but rather a result from degeneration of ascending dopaminergic pathways.
Our studies (this report and Kuhl et aI., 1984 ) demonstrated a moderate decline in global brain glucose metabolism in Parkinson's disease, with no regional brain differences or change in the degree of hyperfrontality as compared with those in age matched controls. The differences in the glucose study as compared to blood flow and oxygen met abolic studies may represent methodological differences, but our findings of a loss of frontal, parietal, and occipital metabolic relationships are consistent with the impression of Bes et al. (1983) that a re gional blood flow change occurs in frontal cortex, and the findings of a change in oxygen utilization in parietal cortex by Lenzi et al. (1979) . Since our findings were present in both Huntington's and Par kinson's diseases and varied with age (Metter et aI., 1983) , it appears that the cortical abnormalities are directly related to changes in basal ganglial func tion.
Our findings in Alzheimer's disease of a gener alized decline in global metabolism and relatively greater decline in frontal and temporal cortex (Benson et a\., 1983 ; this study) are consistent with those of other researchers. Metabolic and flow changes have been found consistently, and fre quently are most prominent in association cortex. The large number of correlations noted in Fig. 5 between frontal measures and between temporal measures results from a uniform decline of the met abolic measures in these regions. With such a de cline, the degree of metabolic correlation will in crease, resulting in an increased number of reliable correlations. The loss of metabolic variability be tween parts of the frontal and temporal regions may be associated with a decline in the ability of the regions to complete functional tasks that require in dependent responses within different parts of each lobe. Thus, the observations of metabolism in Alz heimer's disease suggest a loss of functional inde pendence between regions, which may explain as pects of the dementia.
